bepridil has been researched along with Ventricular Dysfunction, Left in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bepridil was administered to 125 consecutive patients with paroxysmal and persistent atrial fibrillations." | 7.74 | Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation. ( Asano, T; Ito, H; Kawamura, M; Kobayashi, Y; Minoura, Y; Miyoshi, F; Onuki, T; Tanno, K, 2007) |
| "Bepridil was administered to 125 consecutive patients with paroxysmal and persistent atrial fibrillations." | 3.74 | Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation. ( Asano, T; Ito, H; Kawamura, M; Kobayashi, Y; Minoura, Y; Miyoshi, F; Onuki, T; Tanno, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, M | 1 |
| Ito, H | 1 |
| Onuki, T | 1 |
| Miyoshi, F | 1 |
| Minoura, Y | 1 |
| Asano, T | 1 |
| Tanno, K | 1 |
| Kobayashi, Y | 1 |
1 other study available for bepridil and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Ag | 2007 |